SEC Form 4 · accession 0001645627-18-000070
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President
Period of report
Nov 2, 2018
Accepted (ET)
Nov 7, 2018 · 4:43 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 2, 2018 | P | 1,000 | $0.0396 | A | 26,125,498 | D | |
| Common Stock | Nov 2, 2018 | P | 1,000 | $0.0414 | A | 26,126,498 | D | |
| Common Stock | Nov 5, 2018 | P | 1,000 | $0.0379 | A | 26,127,498 | D | |
| Common Stock | Nov 5, 2018 | P | 2,000 | $0.0376 | A | 26,129,498 | D | |
| Common Stock | Nov 5, 2018 | P | 1,000 | $0.0382 | A | 26,130,498 | D | |
| Common Stock | Nov 6, 2018 | P | 2,000 | $0.0385 | A | 26,132,498 | D |
Table II — derivative securities
No Table II lines on this filing.